Impact of extremely early antiretroviral therapy to reduce VIral REservoir and induce functional CURE of HIV-1 infection. A pilot comparative study.
Phase of Trial: Phase III
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Abacavir (Primary) ; Darunavir (Primary) ; Dolutegravir (Primary) ; Emtricitabine (Primary) ; Lamivudine (Primary) ; Maraviroc (Primary) ; Ritonavir (Primary) ; Tenofovir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms VIRECURE
- 10 Jun 2017 Biomarkers information updated
- 16 Aug 2016 Planned End Date changed from 1 May 2017 to 1 Nov 2018.
- 16 Aug 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2018.